Question Period Notes
About this information
In accordance with the Access to Information Act, the government proactively publishes the package of question period notes that were prepared by a government institution for the minister and that were in use on the last sitting day in June and December.
The question period notes may be partially or fully redacted in accordance with the legislation; for example, if the notes contain information related to national security or personal information. (Learn more about exemptions and exclusions.)
If you find a question period note of interest, you may make an access to information request in order to obtain it.
• What is the Government of Canada doing to secure sufficient quantities of PPE in Canada?
• What is the Government of Canada doing in response to the recommendations of the Auditor General?
• Why wasn’t the Government of Canada better prepared to respond to the PPE and medical device needs for the COVID-19 pandemic?
• How is the Public Health Agency of Canada equipping frontline healthcare workers with the PPE required to protect their health and mitigate the spread of COVID-19?
• What is the Government of Canada doing to prepare for resurgence and/or mass vaccination campaign scenarios?
• What is the Government doing to encourage the restart of the Canadian economy while continuing to prevent imported cases of COVID-19?
• What is the Government doing to protect Canadians at the Canada/United States border?
· How does the federal government work with provinces and territories on the collection of race/ethnicity-based data on deaths and active cases?
• How is the Government of Canada assisting jurisdictions with surge capacity needs?
• What is the Government of Canada doing to ensure that Canadians have access to effective COVID-19 testing?
· What is Health Canada doing to ensure Canada has access to the rapid testing devices needed during the COVID-19 pandemic?
• What is Health Canada doing to help Canadians get access to treatments for COVID-19?
• Given recent reports of blood clots following the use of viral vector COVID-19 vaccines (COVISHIELD, AstraZeneca, Janssen) in Canada and internationally, and international reports of myocarditis after mRNA vaccination, What is the Government doing to ensure vaccine safety, including monitoring for adverse reactions to the COVID-19 vaccines?
• How is the Government making its decisions on the safe use of viral vector and mRNA vaccines?